Kun Xu

456 total citations
24 papers, 322 citations indexed

About

Kun Xu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Complementary and alternative medicine. According to data from OpenAlex, Kun Xu has authored 24 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Complementary and alternative medicine. Recurrent topics in Kun Xu's work include Traditional Chinese Medicine Analysis (3 papers), Ferroptosis and cancer prognosis (2 papers) and Ocular Surface and Contact Lens (2 papers). Kun Xu is often cited by papers focused on Traditional Chinese Medicine Analysis (3 papers), Ferroptosis and cancer prognosis (2 papers) and Ocular Surface and Contact Lens (2 papers). Kun Xu collaborates with scholars based in China, Mexico and Taiwan. Kun Xu's co-authors include Mingjing Yan, Tao Shen, Shenghui Sun, Xiuqing Huang, Weiqing Tang, Jian Li, Lin Dou, Jing Pang, Yang Xiang and Genhua Liu and has published in prestigious journals such as Food Chemistry, Small and International Journal of Pharmaceutics.

In The Last Decade

Kun Xu

22 papers receiving 321 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kun Xu 129 65 48 47 46 24 322
Lifang Luo 213 1.7× 77 1.2× 112 2.3× 31 0.7× 32 0.7× 12 420
Caixia Lin 171 1.3× 51 0.8× 37 0.8× 47 1.0× 88 1.9× 17 473
Liuyi Lu 143 1.1× 42 0.6× 86 1.8× 74 1.6× 27 0.6× 16 376
Chenghai Peng 130 1.0× 93 1.4× 29 0.6× 71 1.5× 34 0.7× 17 312
Fengkai Ruan 133 1.0× 68 1.0× 45 0.9× 32 0.7× 106 2.3× 28 346
Meng Yan 230 1.8× 69 1.1× 31 0.6× 34 0.7× 28 0.6× 27 432
Yuesheng Xia 129 1.0× 38 0.6× 101 2.1× 34 0.7× 24 0.5× 13 432
Mengwei Huang 286 2.2× 40 0.6× 55 1.1× 23 0.5× 23 0.5× 17 545
Marta Tkacz 126 1.0× 35 0.5× 34 0.7× 23 0.5× 35 0.8× 32 325
Xiufeng Zheng 135 1.0× 56 0.9× 39 0.8× 98 2.1× 18 0.4× 24 435

Countries citing papers authored by Kun Xu

Since Specialization
Citations

This map shows the geographic impact of Kun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Xu more than expected).

Fields of papers citing papers by Kun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Xu. The network helps show where Kun Xu may publish in the future.

Co-authorship network of co-authors of Kun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Xu. A scholar is included among the top collaborators of Kun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Xu. Kun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Zhipeng, J. Huang, J. Huang, et al.. (2025). pH-regulated nuclear F-actin assembly during ferroptosis. Frontiers in Cell and Developmental Biology. 13. 1699698–1699698.
2.
Jia, Na, et al.. (2024). Shock Wave Therapy Alleviates Hypoxia/Reoxygenation‐Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Ferroptosis. Analytical Cellular Pathology. 2024(1). 8753898–8753898. 2 indexed citations
3.
Li, Wenlin, Kun Xu, Junpeng Gao, et al.. (2024). The dual functions of the pentacyclic triterpenoid madecassic acid in ameliorating doxorubicin-induced cardiotoxicity and enhancing the antitumor efficacy of doxorubicin. International Journal of Biological Sciences. 20(14). 5396–5414. 3 indexed citations
4.
Xu, Kun, Jiannan Wang, Bing Liu, et al.. (2023). Apigenin alleviates oxidative stress-induced myocardial injury by regulating SIRT1 signaling pathway. European Journal of Pharmacology. 944. 175584–175584. 32 indexed citations
5.
Huang, Xiuqing, Mingjing Yan, Hao Chen, et al.. (2023). Better biocompatibility of nitrogen‐doped graphene compared with graphene oxide by reducing cell autophagic flux blockage and cell apoptosis. Journal of Biomedical Materials Research Part A. 112(1). 121–138. 2 indexed citations
6.
Yan, Mingjing, Yuan Cao, Que Wang, et al.. (2022). miR‐488‐3p Protects Cardiomyocytes against Doxorubicin‐Induced Cardiotoxicity by Inhibiting CyclinG1. Oxidative Medicine and Cellular Longevity. 2022(1). 5184135–5184135. 12 indexed citations
7.
8.
Xu, Kun, Shenghui Sun, Mingjing Yan, et al.. (2022). DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression. Frontiers in Oncology. 12. 943032–943032. 38 indexed citations
9.
Meng, Jie, Yiran Zhang, Guolin Wang, et al.. (2022). Conduction of a chemical structure-guided metabolic phenotype analysis method targeting phenylpropane pathway via LC-MS: Ginkgo biloba and soybean as examples. Food Chemistry. 390. 133155–133155. 10 indexed citations
10.
Xu, Kun, et al.. (2022). Antimony accumulation in zebrafish (Danio rerio) and its effect on genotoxicity, histopathology, and ultrastructure. Aquatic Toxicology. 252. 106297–106297. 20 indexed citations
11.
Sun, Shenghui, Kun Xu, Mingjing Yan, et al.. (2022). Delphinidin induces autophagic flux blockage and apoptosis by inhibiting both multidrug resistance gene 1 and DEAD-box helicase 17 expressions in liver cancer cells. Journal of Pharmacy and Pharmacology. 75(2). 253–263. 8 indexed citations
12.
Li, Ke, Kun Xu, Ye He, et al.. (2021). Functionalized Tumor‐Targeting Nanosheets Exhibiting Fe(II) Overloading and GSH Consumption for Ferroptosis Activation in Liver Tumor. Small. 17(40). e2102046–e2102046. 87 indexed citations
13.
Wang, Jinpeng, et al.. (2021). EGCG Regulates Cell Apoptosis of Human Umbilical Vein Endothelial Cells Grown on 316L Stainless Steel for Stent Implantation. Drug Design Development and Therapy. Volume 15. 493–499. 7 indexed citations
14.
Yan, Mingjing, Shenghui Sun, Kun Xu, et al.. (2021). Cardiac Aging: From Basic Research to Therapeutics. Oxidative Medicine and Cellular Longevity. 2021(1). 9570325–9570325. 61 indexed citations
16.
Peng, Bo, Kun He, Kun Xu, et al.. (2019). Characteristics of Giant Embryo Rice and Research Prospect of Its Processing and Utilization. 9(1). 13–13. 1 indexed citations
17.
Wang, Yani, et al.. (2019). Expression of visual system homeobox 1 in human keratoconus. International Journal of Ophthalmology. 12(2). 201–206. 5 indexed citations
18.
Peng, Bo, Kun Xu, Kun He, et al.. (2019). Genetic Basis of Giant Embryo Traits and Effects of Environmental Factors on Giant Embryo Rice. 9(1). 149–149. 1 indexed citations
19.
Zhao, Sihai, et al.. (2008). Proteome Analysis Identifies the Role of Heat Stress in Production of Progeny HCV in Huh7 Cells Harboring Intact HCV. Intervirology. 51(3). 196–202. 1 indexed citations
20.
Xu, Kun, et al.. (2005). Erythropoietin and IL-3 receptor cell surface expression is decreased under conditions that model some aspects of microgravity.. PubMed. 18(2). 111–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026